1. Home
  2. SLE vs CMND Comparison

SLE vs CMND Comparison

Compare SLE & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

N/A

Current Price

$4.62

Market Cap

177.4M

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$0.79

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLE
CMND
Founded
2014
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.4M
2.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SLE
CMND
Price
$4.62
$0.79
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $60.00
N/A
AVG Volume (30 Days)
247.7K
★ 381.4K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,064,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$49.77
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 90.41
N/A
52 Week Low
$0.48
$0.07
52 Week High
$9.00
$4.66

Technical Indicators

Market Signals
Indicator
SLE
CMND
Relative Strength Index (RSI) 48.28 27.87
Support Level $4.06 $0.77
Resistance Level $4.54 $1.27
Average True Range (ATR) 0.51 0.08
MACD -0.03 0.00
Stochastic Oscillator 7.04 6.47

Price Performance

Historical Comparison
SLE
CMND

About SLE Super League Enterprise Inc.

Super League Enterprise Inc connects brands with the gaming population of around 3.5 billion through advertising and branded content programs across gaming and digital media platforms. The Company generates revenue by delivering these programs through proprietary interactive formats, creator content, immersive experiences, data-driven insights, and strategic campaign services designed to improve marketing performance. By translating player behavior into actionable intelligence, Super League serves as a trusted partner helping brands reach and influence consumers who play video games. With a deep understanding of this engaged yet under-monetized audience, it is positioned to capture an increasing share of brand advertising spend as the market evolves.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: